Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Byrne

Showing results (111-120 of 1,004) with videos related to

Pageof 101
Sort By:
Journal of Molecular Biology|January 31, 1998
A novel highly reproducible quantitative competitve RT PCR systemJ Zhang, C D Byrne
Arteriosclerosis, Thrombosis, and Vascular Biology|May 16, 2015
Circulating Markers of Liver Function and Cardiovascular Disease RiskGiovanni Targher, Christopher D Byrne
Current Opinion in Lipidology|June 24, 2015
Importance of early recognition of heterozygous familial hypercholesterolaemiaAidan Ryan, Christopher D Byrne
Digestive Diseases (Basel, Switzerland)|August 23, 2016
Extrahepatic Diseases and NAFLD: The Triangular Relationship between NAFLD, Type 2-Diabetes and DysbiosisEleonora Scorletti, Christopher D Byrne
European Heart Journal|May 5, 2018
Liver fat content, non-alcoholic fatty liver disease, and risk of ischaemic heart diseaseChristopher D Byrne, Giovanni Targher
Evidence-Based Medicine|June 5, 2010
There is a slight increase in incident diabetes risk with the use of statins, but benefits likely outweigh any adverse effects in those with moderate-to-high cardiovascular riskLokpal Bhatia, Christopher D Byrne
Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes|August 1, 1990
Posterior fossa epidermoid in a member of a kindred with von Hippel-Lindau diseaseS Aggarwal, B D Byrne
Arteriosclerosis, Thrombosis, and Vascular Biology|April 19, 2014
Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular diseaseChristopher D Byrne, Giovanni Targher
Annual Review of Nutrition|July 19, 2013
Omega-3 fatty acids, hepatic lipid metabolism, and nonalcoholic fatty liver diseaseE Scorletti, C D Byrne
Diabetologia|April 8, 2016
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: is universal screening appropriate?Christopher D Byrne, Giovanni Targher
Pageof 101

Showing results (111-120 of 1,004) with videos related to

Sort By:
Pageof 101
Journal of Molecular Biology|January 31, 1998
A novel highly reproducible quantitative competitve RT PCR systemJ Zhang, C D Byrne
Arteriosclerosis, Thrombosis, and Vascular Biology|May 16, 2015
Circulating Markers of Liver Function and Cardiovascular Disease RiskGiovanni Targher, Christopher D Byrne
Current Opinion in Lipidology|June 24, 2015
Importance of early recognition of heterozygous familial hypercholesterolaemiaAidan Ryan, Christopher D Byrne
Digestive Diseases (Basel, Switzerland)|August 23, 2016
Extrahepatic Diseases and NAFLD: The Triangular Relationship between NAFLD, Type 2-Diabetes and DysbiosisEleonora Scorletti, Christopher D Byrne
European Heart Journal|May 5, 2018
Liver fat content, non-alcoholic fatty liver disease, and risk of ischaemic heart diseaseChristopher D Byrne, Giovanni Targher
Evidence-Based Medicine|June 5, 2010
There is a slight increase in incident diabetes risk with the use of statins, but benefits likely outweigh any adverse effects in those with moderate-to-high cardiovascular riskLokpal Bhatia, Christopher D Byrne
Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes|August 1, 1990
Posterior fossa epidermoid in a member of a kindred with von Hippel-Lindau diseaseS Aggarwal, B D Byrne
Arteriosclerosis, Thrombosis, and Vascular Biology|April 19, 2014
Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular diseaseChristopher D Byrne, Giovanni Targher
Annual Review of Nutrition|July 19, 2013
Omega-3 fatty acids, hepatic lipid metabolism, and nonalcoholic fatty liver diseaseE Scorletti, C D Byrne
Diabetologia|April 8, 2016
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: is universal screening appropriate?Christopher D Byrne, Giovanni Targher
Pageof 101